Embolism

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Embolism trials you may qualify for

100

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 51 trials

RecruitingNot Applicable

NCT07575867

CLOT-LESS - CLOsure Tailored: LEss Antithrombotic Strategy After LAAC for Stroke Prevention

This is a prospective, non-randomized, observational cohort study conducted at the FSBI "NMRC TPM" of the Ministry of Healthcare of the Russian Federation. Left…

Russia464 participantsStarted 2026-04

Treatment: Left Atrial Appendage Closure, Apixaban 2.5 mg BID

RecruitingNot Applicable

NCT05791786

The Establishment of a Registry and a Biorepository of Patients With Suspected Amniotic Fluid Embolism (AFE)

To establish a clinical registry of suspected cases of AFE. The existing registry will be migrated to a new platform,

United States400 participantsStarted 2022-07-05

Treatment: Patient

RecruitingNot Applicable

NCT06588634

The PERSEVERE Study

Randomized Controlled Trial of High-Risk Pulmonary Embolism Comparing FlowTriever System vs. Standard of Care

United States200 participantsStarted 2024-12-16

Treatment: FlowTriever System, Standard of Care

RecruitingNot Applicable

NCT07575503

Diagnostic Value of Photon-Counting CT in Subsegmental Pulmonary Embolism

Pulmonary embolism (PE) is a serious and potentially life-threatening condition caused by blood clots in the lungs. A particular type, subsegmental pulmonary em…

China696 participantsStarted 2026-01-01

RecruitingPhase 3

NCT05627375

Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets

Venous thromboembolism (VTE) and atherosclerotic cardiovascular disease share common risk factors and frequently coexist in the same patients. Their management…

France1,400 participantsStarted 2023-08-16

Treatment: Full-dose anticoagulant therapy (AC), Antiplatelet therapy (AP)

RecruitingNot Applicable

NCT07363525

Michigan Initial Experience Using Tigertriever for Thrombectomy

The purpose of this research study is to collect data about the effectiveness (i.e. how the device works) and safety (how safe it is to use such a device) of th…

United States150 participantsStarted 2026-01-15

Treatment: Mechanical Thrombectomy

All recent trials (100 shown)

SuspendedNot Applicable

NCT06168942

A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination

The purpose of this study is to compare the safety and effectiveness of Laminar Left Atrial Appendage Closure (LAAC) device as compared to the commercially avai…

United States1,500 participantsStarted 2024-02-19

Treatment: Experimental: Laminar Left Atrial Appendage Closure System, Active Comparator: WATCHMAN / Amulet

Active — Not RecruitingPhase 3

NCT04444492

Combination of Ranibizumab and Targeted Laser Photocoagulation

Intravitreal injections of Ranibizumab will be applied in all patients according to treatment guidelines. The experimental group will receive additional targete…

Austria, Germany88 participantsStarted 2020-08-25

Treatment: Ranibizumab Injection, Laser photocoagulation

Embolism

Trial phase breakdown

Trial status

Actively recruiting — 51 trials

CLOT-LESS - CLOsure Tailored: LEss Antithrombotic Strategy After LAAC for Stroke Prevention

The Establishment of a Registry and a Biorepository of Patients With Suspected Amniotic Fluid Embolism (AFE)

The PERSEVERE Study

Diagnostic Value of Photon-Counting CT in Subsegmental Pulmonary Embolism

Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets

Michigan Initial Experience Using Tigertriever for Thrombectomy

All recent trials (100 shown)

A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination

Combination of Ranibizumab and Targeted Laser Photocoagulation

Trial phase breakdown

Trial status

Actively recruiting — 51 trials

CLOT-LESS - CLOsure Tailored: LEss Antithrombotic Strategy After LAAC for Stroke Prevention

The Establishment of a Registry and a Biorepository of Patients With Suspected Amniotic Fluid Embolism (AFE)

The PERSEVERE Study

Diagnostic Value of Photon-Counting CT in Subsegmental Pulmonary Embolism

Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets

Michigan Initial Experience Using Tigertriever for Thrombectomy

All recent trials (100 shown)

A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination

Combination of Ranibizumab and Targeted Laser Photocoagulation

The Role of Platelet TLRs in Platelet Activation During VTE

The ReCAna for Lower ExtremIty Venous OBstructions and In-StEnt Restenosis Registry

The OAT Trail: The Obesity Anti-Coagulation Thromboprophylaxis Trial.

Acute or Subacute Iliofemoral Vein Thrombosis: Aspiration for Flow Restoration Versus Standard Anticoagulation

Personalized Medicine Decision-Making in a Virtual Clinical Setting

Sub-Clinical Atrial Fibrillation Biomarker Study

Pilot Study to Evaluate the Role of EBUS in the Diagnosis of Acute PE in Critically Ill Patients

Clinical Scores, Biomarkers, and CT Findings in Acute Pulmonary Embolism

Platelet Function and Impella Support

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications

Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism

Hemodynamic and Respiratory Instability During Percutaneous Pulmonary Thrombectomy

ClotTriever® Thrombectomy System Use-Result Survey in Japan

Genetic Markers of Patients With History of Pulmonary Embolism Post Total Joint Arthroplasty

The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study

A Real-World Study of EkoSonic Endovascular System in Chinese Populations With Acute Pulmonary Embolism

3D-EIT for Diagnosis and Monitoring of Pulmonary Embolism

Screening for Pulmonary Embolism Using Single-channel Electrocardiogram